PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
18-Jan-2021 ADDING MULTIMEDIA — ENHERTU® Approved in the U.S. for the Treatment of Patients with Previously Treated HER2 Positive Advanced Gastric Cancer Businesswire
18-Jan-2021 Global Sleep Apnea Devices Market Booming Demand Leading To Exponential CAGR Growth By 2025 CDN Newswire
18-Jan-2021 Global Pyrogen Testing Market Booming Demand Leading To Exponential CAGR Growth By 2025 CDN Newswire
18-Jan-2021 Global Platelet-rich Plasma Market Booming Demand Leading To Exponential CAGR Growth By 2025 CDN Newswire
18-Jan-2021 Global Pharmaceutical Waste Management Market Booming Demand Leading To Exponential CAGR Growth By 2025 CDN Newswire
18-Jan-2021 Global Microarray Market Booming Demand Leading To Exponential CAGR Growth By 2025 CDN Newswire
18-Jan-2021 Global Leukapheresis Market Booming Demand Leading To Exponential CAGR Growth By 2025 CDN Newswire
18-Jan-2021 Global Hormonal Contraceptive Market Booming Demand Leading To Exponential CAGR Growth By 2025 CDN Newswire
18-Jan-2021 Global Heart Transplant Market Booming Demand Leading To Exponential CAGR Growth By 2025 CDN Newswire
18-Jan-2021 Global Flow Cytometry Market Booming Demand Leading To Exponential CAGR Growth By 2025 CDN Newswire
18-Jan-2021 Global Flexible Endoscopes Market Booming Demand Leading To Exponential CAGR Growth By 2025 CDN Newswire
17-Jan-2021 Registration Opens for SMi’s 5th Annual Highly Potent Active Pharmaceutical Ingredients Conference (HPAPi) SMi Group
17-Jan-2021 Mayo Clinic Laboratories and American Hospital Dubai Announce Strategic Partnership Businesswire
17-Jan-2021 Servier anuncia resultados atualizados de sobrevida geral do estudo exploratório de fase II TASCO1 do LONSURF® + bevacizumabe em um ambiente de primeira linha para pacientes com CCRm não ressecável não elegíveis para terapia intensiva Businesswire
17-Jan-2021 JS Bio and Etta Biotech Advancing Strategic Partnership Businesswire
16-Jan-2021 Servier announce updated overall survival results of exploratory TASCO1 phase II study of LONSURF® + bevacizumab in a first-line setting for patients with unresectable mCRC non-eligible for intensive therapy Businesswire
16-Jan-2021 BIOMARIN INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of BioMarin Pharmaceutical Inc. - BMRN Businesswire
16-Jan-2021 Carbon Health Launches COVID-19 Vaccination Platform to Accelerate National Rollout Businesswire
14-Jan-2021 AltPep Raises $23M Jumpstarting Work on Alzheimer's Disease Newswire
14-Jan-2021 Teva Announces Launch of a Generic Version of NuvaRing® (etonogestrel and ethinyl estradiol) Vaginal Ring in the United States Businesswire